Literature DB >> 16521035

5-HT receptor subtypes involved in the anxiogenic-like action and associated Fos response of acute fluoxetine treatment in rats.

Peter Salchner1, Nicolas Singewald.   

Abstract

RATIONALE: We have recently reported that acute treatment with the selective serotonin reuptake inhibitor fluoxetine exacerbates escape responses to airjet and facilitates airjet-induced activation of locus coeruleus (LC) neurons.
OBJECTIVE: Here we aimed to identify the 5-HT receptor subtype(s) mediating the anxiogenic-like effects of acute fluoxetine in this paradigm and to study whether chronic fluoxetine treatment would alter these responses.
METHODS: The expression of the immediate early gene c-fos was used as a marker of neuronal activation.
RESULTS: Acute fluoxetine increased the airjet-induced escape behaviour and Fos expression in the LC of saline-pretreated rats. Pretreatment with the 5-HT(2C/2B) antagonist SB 206553, but not with the 5-HT1A antagonist WAY 100635, the 5-HT1B antagonist SB 224289 or the 5-HT3 antagonist Y-25130 inhibited the fluoxetine-induced increase in escape behaviour and the associated elevated LC Fos response. The selective 5-HT2C agonist MK-212 mimicked the anxiogenic response of fluoxetine. Chronic treatment with fluoxetine abolished the anxiogenic-like effect and led to a normalization of the enhanced fluoxetine-induced Fos response to airjet.
CONCLUSIONS: Taken together, the results indicate that the anxiogenic-like effect as well as the facilitated neuronal reactivity induced by acute fluoxetine in the airjet model is mediated primarily by activation of 5-HT2C receptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16521035     DOI: 10.1007/s00213-005-0247-5

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  49 in total

Review 1.  The medical benefit of 5-HT research.

Authors:  Brian J Jones; Thomas P Blackburn
Journal:  Pharmacol Biochem Behav       Date:  2002-04       Impact factor: 3.533

2.  Modulation of the firing activity of noradrenergic neurones in the rat locus coeruleus by the 5-hydroxtryptamine system.

Authors:  N Haddjeri; C de Montigny; P Blier
Journal:  Br J Pharmacol       Date:  1997-03       Impact factor: 8.739

Review 3.  Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus.

Authors:  J Harro; L Oreland
Journal:  Brain Res Brain Res Rev       Date:  2001-12

4.  A 5-hydroxytryptamine2 agonist augments gamma-aminobutyric acid and excitatory amino acid inputs to noradrenergic locus coeruleus neurons.

Authors:  C Chiang; G Aston-Jones
Journal:  Neuroscience       Date:  1993-05       Impact factor: 3.590

Review 5.  Molecular targets in the treatment of anxiety.

Authors:  Justine M Kent; Sanjay J Mathew; Jack M Gorman
Journal:  Biol Psychiatry       Date:  2002-11-15       Impact factor: 13.382

6.  A direct brainstem-amygdala-cortical 'alarm' system for subliminal signals of fear.

Authors:  Belinda J Liddell; Kerri J Brown; Andrew H Kemp; Matthew J Barton; Pritha Das; Anthony Peduto; Evian Gordon; Leanne M Williams
Journal:  Neuroimage       Date:  2005-01-01       Impact factor: 6.556

7.  Antidepressant-like behavioral effects mediated by 5-Hydroxytryptamine(2C) receptors.

Authors:  J F Cryan; I Lucki
Journal:  J Pharmacol Exp Ther       Date:  2000-12       Impact factor: 4.030

8.  Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents.

Authors:  Nicholas Jones; Mark S Duxon; Sheila M King
Journal:  Psychopharmacology (Berl)       Date:  2002-04-05       Impact factor: 4.530

Review 9.  Role of selective serotonin reuptake inhibitors in psychiatric disorders: a comprehensive review.

Authors:  Meera Vaswani; Farzana Kadar Linda; Subramanyam Ramesh
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2003-02       Impact factor: 5.067

10.  Comparison of stimulus properties of fluoxetine and 5-HT receptor agonists in a conditioned taste aversion procedure.

Authors:  H H Berendsen; C L Broekkamp
Journal:  Eur J Pharmacol       Date:  1994-02-21       Impact factor: 4.432

View more
  8 in total

Review 1.  Pharmacology of cognitive enhancers for exposure-based therapy of fear, anxiety and trauma-related disorders.

Authors:  N Singewald; C Schmuckermair; N Whittle; A Holmes; K J Ressler
Journal:  Pharmacol Ther       Date:  2014-12-27       Impact factor: 12.310

2.  Acute anxiogenic-like effects of selective serotonin reuptake inhibitors are attenuated by the benzodiazepine diazepam in BALB/c mice.

Authors:  Melissa A Birkett; Nina M Shinday; Eileen J Kessler; Jerrold S Meyer; Sarah Ritchie; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2011-03-21       Impact factor: 3.533

3.  Differential effects of acute and repeated citalopram in mouse models of anxiety and depression.

Authors:  Cedric Mombereau; Tamar L Gur; Jennifer Onksen; Julie A Blendy
Journal:  Int J Neuropsychopharmacol       Date:  2009-12-14       Impact factor: 5.176

4.  Factors influencing fluoxetine-induced sexual dysfunction in female rats.

Authors:  Sarah Adams; Danyeal Heckard; James Hassell; Lynda Uphouse
Journal:  Behav Brain Res       Date:  2012-07-23       Impact factor: 3.332

Review 5.  Dual- and triple-acting agents for treating core and co-morbid symptoms of major depression: novel concepts, new drugs.

Authors:  Mark J Millan
Journal:  Neurotherapeutics       Date:  2009-01       Impact factor: 7.620

6.  Altered 5-HT2C receptor agonist-induced responses and 5-HT2C receptor RNA editing in the amygdala of serotonin transporter knockout mice.

Authors:  Pablo R Moya; Meredith A Fox; Catherine L Jensen; Justin L Laporte; Helen T French; Jens R Wendland; Dennis L Murphy
Journal:  BMC Pharmacol       Date:  2011-04-07

7.  Cellular correlates of enhanced anxiety caused by acute treatment with the selective serotonin reuptake inhibitor fluoxetine in rats.

Authors:  Shilpa Ravinder; Anup G Pillai; Sumantra Chattarji
Journal:  Front Behav Neurosci       Date:  2011-12-28       Impact factor: 3.558

8.  Differences in Anxiety-Like Behavior within a Batch of Wistar Rats Are Associated with Differences in Serotonergic Transmission, Enhanced by Acute SRI Administration, and Abolished By Serotonin Depletion.

Authors:  Jakob Näslund; Erik Studer; Robert Pettersson; Melker Hagsäter; Staffan Nilsson; Hans Nissbrandt; Elias Eriksson
Journal:  Int J Neuropsychopharmacol       Date:  2015-02-25       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.